Orally administered arctigenin alleviated colitis in mice by enhancing mucosal healing, primarily through accelerating colonic epithelial cell migration without affecting proliferation through the activation of the focal adhesion kinase (FAK) 496. This evidence concerns the gene PTK2 and colitis.